Quality Cancer Care is at the heart of the European Cancer Organisation’s guiding mission: 'To reduce the burden of cancer, improve outcomes and the quality of care for cancer patients, through multidisciplinarity and multiprofessionalism. The consequences of delayed treatment can be particularly severe for Scope of the Mission Cancer affects everyone regardless of age, gender or social status and represents a tremendous burden for patients, families, and societies at large. Mar 19, 2025 · Improving outcomes across Europe, and for all cancer types, is a political priority for the EU. A questionnaire is an instrument designed to assess some of the different aspects that define the quality of life (QOL) of cancer patients or survivors. We also included the extension of therapeutic indications of drugs originally approved for the treatments of cancer in adults (i. Cancer patients diagnosed during 1995-99, on average, lived 11. 1 years after diagnosis in the United States, compared to just 9. PERITONEAL CANCER. Mar 27, 2025 · “As patients with lung cancer are living longer and receiving treatment for many years, efficiencies must be found,” comments Juergens, who points out that SC administration is linked to reductions in pharmacy preparation, nursing administration time, infusion-chair occupancy and fewer infusion-related AEs than with IV administration American Thyroid Association's clinical practice guidelines are the leading resources for diagnosing and treating thyroid disease and thyroid cancer. Europe urgently needs to renew its commitment to cancer prevention, treatment and care that recognises the growing challenges around cancer and reflects the developments in cancer care. Jun 4, 2025 · The European Organisation for Research and Treatment of Cancer (EORTC) is pleased to announce the publication of its 2024 Annual Report, now available online here. Discover comprehensive cancer treatment options in Europe, including advanced therapies, expert care, and world-class facilities. The European Cancer Information System (ECIS), launched in 2018, is the reference for monitoring and projecting the burden of cancer in Europe. Jun 27, 2024 · Why treating cancer in Europe? What you should know about cancer treatment in Europe. L. While conventional treatments such as surgery, chemotherapy, and radiation therapy have made significant strides in combating cancer, there is growing interest in alternative cancer treatments in Europe that offer a more holistic and patient-centred approach. ' In recent decades, advancements in cancer care have Receiving a cancer diagnosis is a life-altering moment. Apr 15, 2025 · The European Organisation for Research and Treatment of Cancer (EORTC) is a non-governmental, non-profit organisation, which unites clinical cancer research experts, throughout Europe, to define better treatments for cancer patients to prolong survival and improve quality of life. 301 Moved Permanently 301 Moved Permanently nginx Nov 12, 2024 · Europe has exciting opportunities for improving cancer care and patient outcomes within its grasp. Jan 15, 2020 · Among the key findings of the Comparator Report on Cancer in Europe 2020, is what looks like a paradox: although more people are being diagnosed with cancer, a smaller proportion of those people appear to be dying from the disease. In this opinion piece, find out how both equity and equality of access can be improved. The report, a comprehensive overview of major cancer trends across Europe, quickly unravels the mystery. Adopted in 2021 with a budget of €4 billion, including €1. We saw significant innovation for the treatment of conditions like multiple myeloma, leukaemia, lymphomas, biliary tract cancer and We would like to show you a description here but the site won’t allow us. Dec 18, 2024 · Cancer survival estimates in Europe highlight notable geographical and economic disparities. Feb 27, 2024 · New research shows people in the UK were treated with chemotherapy and radiotherapy less often, and waited longer to start cancer treatment Cancer is one of the main priorities of the European Commission in the health domain. Three years after its adoption, Europe’s Beating Cancer Plan is already making a positive impact on people’s lives by boosting collaboration and forging a path towards better prevention, early detection, treatment and care as well as improving the quality of life of cancer patients and survivors. For patients, the period between diagnosis and the start of treatment often becomes an agonising wait, amplifying feelings of anxiety, helplessness, and emotional distress. As an independent, non-profit cancer research organisation, the European Organisation for Research and Treatment of Cancer (EORTC) has been active in sharing its decades of experience in the field. It lists: the newest and most recently updated medicines authorised for the treatment of cancer in the European Union (EU); any recent opinions on anti-cancer medicines that are pending authorisation by the European Commission (EC); EMA's latest cancer-related news announcements; EMA's events on Feb 15, 2022 · Europe's Beating Cancer Plan is a key pillar of the European Health Union, presented by European Commission President Ursula von der Leyen in November 2020, calling for a more secure, resilient and better-prepared European Union.

fogu3xro
wo60s2n
fnlutiqc
scajvxl
clciypy9
3m3dqcxyp
hw11fi
bcujc1jh
fbddp46x
scvi4v